A Aralex Aachen research explorer

November 23, 2016 article Open access

Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)

International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2016.11.027 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 4 stored of 164

The impact of bone marrow sparing on organs at risk dose for cervical cancer: a Pareto front analysis
2023 Frontiers in Oncology article Physics and Astronomy Advanced Radiotherapy Techniques Open access

7

citations
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy
2021 International Journal of Radiation Oncology*Biology*Physics article Medicine Endometrial and Cervical Cancer Treatments Open access

23

citations
Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review
2021 Radiotherapy and Oncology review Physics and Astronomy Advanced Radiotherapy Techniques Open access

76

citations
NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update
2020 International Journal of Radiation Oncology*Biology*Physics article Medicine Endometrial and Cervical Cancer Treatments Open access

158

citations

4 results

References 0